Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,220 shares of common stock on 08/02/2024, as per the latest filing. The shares, valued at an aggregate market price of $47,063, were acquired on 08/01/2024 through a restricted stock vest from the company itself. This transaction follows a previous sale of 1,775 shares by Matsuda in the past three months, which had gross proceeds of $15,988.